Piramal Pharma Board Meeting on Oct 27 to Approve Unaudited Financial Results

Piramal Pharma Ltd has announced that its Board of Directors will convene on October 27, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results, both standalone and consolidated, for the quarter and half-year ended September 30, 2026. Concurrently, the company has informed that the trading window for its securities will be closed from October 1, 2026, and will reopen on October 29, 2026, to prevent insider trading during the period leading up to the results announcement.